HKIM
CRMD icon

Hayek Kallen Investment Management’s CorMedix CRMD Stock Holding History

Hayek Kallen Investment Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107K Buy
+15,728
New +$116K 0.03% 92
2025
Q4 		– Sell
-29,443
Closed -$342K – 112
2025
Q3 		$342K Buy
+29,443
New +$356K 0.11% 78

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Hayek Kallen Investment Management's CRMD Position: Q1 2026 in Review

Hayek Kallen Investment Management opened a new position in CorMedix (CRMD) in Q1 2026: 15,728 shares worth $107K. The stake represents 0.03% of the portfolio and ranks #92 among its holdings. This is a return to the name: Hayek Kallen Investment Management previously reported a position in CRMD as recently as Q3 2025.

Hayek Kallen Investment Management first reported a position in CRMD in Q3 2025 and has held it in 2 quarters since. The position peaked at $342K in Q3 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Hayek Kallen Investment Management held 15,728 shares of CorMedix worth $107K as of Q1 2026.
  • CorMedix was a new Hayek Kallen Investment Management position in Q1 2026.
  • CorMedix made up 0.03% of Hayek Kallen Investment Management's portfolio in Q1 2026, its #92 holding.
  • Hayek Kallen Investment Management first reported a position in CorMedix in Q3 2025 and has held it in 2 quarters since.
  • Hayek Kallen Investment Management's CorMedix position peaked at $342K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Hayek Kallen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.